Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines

Logan R F; Van Staa T P
October 2003
Gut;Oct2003, Vol. 52 Issue 10, p1530
Academic Journal
No abstract available.


Related Articles

  • Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Ransford, R.A.J.; Langman, M.J.S. // Gut;Oct2002, Vol. 51 Issue 4, p536 

    Background: 5-Aminosalicylates are extensively prescribed for the treatment of ulcerative colitis but have a wide range of described adverse effects. Aims: To determine whether serious adverse effect profiles differ for sulphasalazine and mesalazine. Methods: Analysis of suspected serious...

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;6/23/2012, Issue 1407, p3 

    This section offers news briefs related to adverse reactions, including reports of serious pulmonary reactions received by the Centre for Adverse Reactions Monitoring (CARM) following the use of nitrofurantoin and the launch of the suspected medicine adverse reaction search (SMARS) database by...

  • Medsafe recommends close monitoring of clozapine.  // Reactions Weekly;Jun2015, Vol. 1557 Issue 1, p4 

    The article reports that the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) suggested that a number of serious adverse reactions are associated with use of the atypical antipsychotic clozapine, and close monitoring is essential to reduce the occurrence of adverse reactions.

  • Man sees what he suspects.  // British Medical Journal (Clinical Research Edition);6/1/1985, Vol. 290 Issue 6482, p1654 

    Reports the role of the Committee on Safety of Medicine in licensing and monitoring adverse effects of drugs. Association between thalidomide and congenital malformations; Efficacy of yellow card technique to suspect the association between the clinical state and effect of drug on patient;...

  • MEDICAL NEWS.  // British Medical Journal;8/5/1978, Vol. 2 Issue 6134, p442 

    Reports developments related to medicine in Great Britain as of August 1978. Appointment of H.L Duthie as provost of the Welsh National School of Medicine; Number of suspected adverse reactions to drugs reported in the Committee on Safety Medicines; Schedule of medical congresses.

  • On-line reporting of adverse reactions.  // WHO Drug Information;2002, Vol. 16 Issue 4, p284 

    Reports that the Australian Adverse Drug Reactions Advisory Committee has commissioned a database and online reporting of suspected adverse reactions. Procedure for accessing the facility.

  • Updates from Medsafe.  // Reactions Weekly;3/17/2012, Issue 1393, p4 

    The article offers updates from New Zealand's Medsafe regarding adverse drug reactions (ADR) and safety and efficacy of drugs. It warns the risk of bleeding associated with anticoagulants and antiplatelets. The Medicines Adverse Reaction Committee (MARC) concluded that there is insufficient...

  • VPC recommends streamlining adverse reaction surveillance scheme.  // Veterinary Record: Journal of the British Veterinary Association;10/23/2004, Vol. 155 Issue 17, p506 

    Cites a report by the Veterinary Products Committee (VPC) on the effectiveness of the suspected adverse reaction surveillance scheme (SARSS) of the Veterinary Medicines Directorate in Great Britain. Means of reporting both human and animal suspected adverse reactions; Recommendations of the VPC...

  • Adverse drug reactions and the liver.  // British Medical Journal (Clinical Research Edition);7/6/1985, Vol. 291 Issue 6487, p46 

    Reports on the Committee on Safety of Medicines explanation on adverse drug reactions and the liver. Importance of liver for metabolic transformation of drugs; Incidence of hepatic drug reactions; Classes of drugs that produce liver reactions.

  • First reports of serious adverse drug reactions in recent weeks.  // Drugs & Therapy Perspectives;Nov2009, Vol. 25 Issue 11, p19 

    A chart is presented that lists case reports of serious adverse drug reactions (ADRs) published in the drug safety newsletter "Reactions Weekly."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics